Skip to main content

The Better Question: Are You Measuring Disease—or Measuring Health?

Erika Schultz, LAc, DACM, ACN
Erika Schultz, LAc, DACM, ACN

Founder, The Resiliency Method™

Dr. Darren Schmidt
Dr. Darren Schmidt

Dr. Darren Schmidt, DC

7 hours ago
  • Your Blood Can Predict How Long You’ll Live—And You Can Change the Outcome The MVX Plus test, developed from over a decade of NIH research on 30,000+ people and validated on 270,000 more through the UK Biobank, identifies six biomarkers that predict five-year mortality. Dr. Schmidt explains that a high score isn’t a life sentence—it’s a starting point for improvement, and patients can track their progress over time.
  • Thiamine (B1) Deficiency Is More Common—and More Impactful—Than Most Doctors Realize Dr. Schmidt shares his own health scare from an undetected gas leak and how high-dose B1 (benfotiamine and TTFD) transformed his recovery. He explains that four of the six MVX Plus markers are directly tied to B1 status, making it one of the most overlooked nutrients in chronic illness care.
  • Testing Should Guide Treatment, Not Replace It While MVX Plus offers an affordable, trackable way to monitor toxicity, inflammation, and mitochondrial function, Dr. Schultz and Dr. Schmidt agree: lab results provide direction, but real healing still requires individualized, sequenced care—not a one-size-fits-all protocol.

Comments